Heterogeneity of insulin resistance and beta cell dysfunction in gestational diabetes mellitus: a prospective cohort study of perinatal outcomes
- PMID: 30355279
- PMCID: PMC6201515
- DOI: 10.1186/s12967-018-1666-5
Heterogeneity of insulin resistance and beta cell dysfunction in gestational diabetes mellitus: a prospective cohort study of perinatal outcomes
Abstract
Background: Insulin resistance and beta cell dysfunction were reported to be responsible for gestational diabetes mellitus (GDM). However, little is known about the heterogeneity of these factors and its influences on perinatal outcomes. We investigated whether subtypes of insulin resistance and beta cell dysfunction in gestational diabetes mellitus have different impacts on perinatal outcomes.
Methods: In this prospective cohort study, we followed 554 pregnant women and glucose challenge test was performed at 24-28th weeks of their gestation. Women with plasma glucose ≥ 7.8 mmol/L would be included and advised to undergo the diagnostic 75-g, 3-h oral glucose tolerance test. According to indices of measuring insulin resistance or beta cell function were below the 25th percentile of women with normal glucose tolerance (NGT), women with GDM were defined as three subtypes: GDM with the beta cell dysfunction, GDM with the insulin resistance defect or GDM with both traits mentioned above (GDM-mixed). Perinatal outcomes were documented.
Results: The levels of prepregnancy and maternal BMI in the GDM-mix group were higher compared to women in the NGT group (23.2 ± 4.0 vs 20.8 ± 3.7 kg/m2, P < 0.001; 24.5 ± 4.3 vs 21.8 ± 3.4 kg/m2, P < 0.001, respectively). Furthermore, women in GDM-mix group more likely to be subjected to LGA (P = 0.008) adverse perinatal outcomes (P = 0.005), although these differences were normalized after adjusting age, prepregnancy and maternal BMI (GDM-mix vs. NGT: P = 0.141 for LGA and P = 0.186 for adverse outcomes). On the other hand, all perinatal outcomes were similar between other two GDM subgroups and NGT group.
Conclusions: Women with GDM display respective characteristics on metabolism disorders and confer discriminating risks of adverse perinatal outcomes because of this heterogeneity.
Keywords: Beta cell dysfunction; Gestational diabetes mellitus; Insulin resistance; Perinatal outcome.
Figures
Similar articles
-
Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance.Diabetologia. 2019 Nov;62(11):2118-2128. doi: 10.1007/s00125-019-4961-7. Epub 2019 Jul 23. Diabetologia. 2019. PMID: 31338546
-
Characteristics and pregnancy outcomes of subtypes of gestational diabetes mellitus based on HOMA-IR and BMI.Arch Gynecol Obstet. 2024 Nov;310(5):2355-2361. doi: 10.1007/s00404-024-07733-6. Epub 2024 Sep 17. Arch Gynecol Obstet. 2024. PMID: 39287682 Review.
-
Contribution of gestational diabetes mellitus heterogeneity and prepregnancy body mass index to large-for-gestational-age infants-A retrospective case-control study.J Diabetes. 2021 Apr;13(4):307-317. doi: 10.1111/1753-0407.13113. Epub 2020 Sep 30. J Diabetes. 2021. PMID: 32935481
-
Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.Diabetes Care. 1997 Nov;20(11):1717-23. doi: 10.2337/diacare.20.11.1717. Diabetes Care. 1997. PMID: 9353615
-
Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management.Diabetes. 1991 Dec;40 Suppl 2:18-24. doi: 10.2337/diab.40.2.s18. Diabetes. 1991. PMID: 1748255 Review.
Cited by
-
Eupatilin mitigates Gestational diabetes in streptozotocin-induced diabetic pregnant rats through the Regulation of inflammation and oxidative stress.Heliyon. 2024 May 8;10(10):e30911. doi: 10.1016/j.heliyon.2024.e30911. eCollection 2024 May 30. Heliyon. 2024. PMID: 38818188 Free PMC article.
-
Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk.Curr Atheroscler Rep. 2025 Jan 20;27(1):27. doi: 10.1007/s11883-024-01273-9. Curr Atheroscler Rep. 2025. PMID: 39832115 Free PMC article. Review.
-
Mouse Models of Gestational Diabetes Mellitus and Its Subtypes: Recent Insights and Pitfalls.Int J Mol Sci. 2023 Mar 22;24(6):5982. doi: 10.3390/ijms24065982. Int J Mol Sci. 2023. PMID: 36983056 Free PMC article. Review.
-
Pregnancy as an Early Cardiovascular Moment: Peripartum Cardiovascular Health.Circ Res. 2023 Jun 9;132(12):1584-1606. doi: 10.1161/CIRCRESAHA.123.322001. Epub 2023 Jun 8. Circ Res. 2023. PMID: 37289905 Free PMC article. Review.
-
Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus.Nutrients. 2022 Jun 13;14(12):2444. doi: 10.3390/nu14122444. Nutrients. 2022. PMID: 35745174 Free PMC article.
References
-
- Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, et al. Gestational diabetes and pregnancy outcomes—a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12:23. doi: 10.1186/1471-2393-12-23. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 2017YFC1309601/National Key R & D Program of China/International
- 81770802/National Natural Science Foundation of China/International
- 15411953100/Shanghai Science & Technology Pillar Program in the Field of Medicine and Agriculture/International
- 20152232/Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support/International
LinkOut - more resources
Full Text Sources